(Q58136243)

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Telmisartan, ramipril, or both in patients at high risk for vascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Telmisartan to prevent recurrent stroke and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Effects of intensive blood-pressure control in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Treatment of hypertension in patients 80 years of age or older

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Sodium-lithium countertransport: physiology and function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Impact of high-normal blood pressure on the risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Blood pressure reduction and cardiovascular outcomes: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Sympathetic deactivation as a goal of nonpharmacologic and pharmacologic antihypertensive treatment: rationale and options

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Chlorthalidone - a renaissance in use?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Hydrochlorothiazide versus chlorthalidone in the management of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

New-onset diabetes and antihypertensive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Mortality amongst patients of the Glasgow Blood Pressure Clinic was high in the 1970s and 80s but has fallen since, why?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Survival in treated hypertension: follow up study after two decades

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Blood pressure control according to new guidelines targets in low- to high-risk hypertensives managed in specialist practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: results of the ForLife study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922

Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.543922